Propellon Therapeutics
Latest round
- Seed
Last raised
- Mar 2017
Total raised
- $2.3M
Investors
- 1
About Propellon Therapeutics
Founded in 2016 and based in Toronto, Canada, Propellon Therapeutics Inc. operates as a developer of cancer therapeutics that targets the WDR5 protein.
Who invested in Propellon Therapeutics
1 investor across 1 round
See all investors in Propellon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 22, 2017
Amount
$2.3M
Investors
Questions about Propellon Therapeutics
Who invested in Propellon Therapeutics?
Propellon Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Propellon Therapeutics raised?
Propellon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Propellon Therapeutics last raise money?
Propellon Therapeutics's most recent round on record is a Seed, in Mar 2017.
What does Propellon Therapeutics do?
Founded in 2016 and based in Toronto, Canada, Propellon Therapeutics Inc.
Where is Propellon Therapeutics headquartered?
Propellon Therapeutics is headquartered in Toronto, Canada.
Which VCs invest in companies like Propellon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare specialists companies at Propellon Therapeutics's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Seed
Raising like Propellon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.